Literature DB >> 31970517

The association between health-related quality of life and achievement of personalized symptom goal.

Keita Tagami1,2, Takashi Kawaguchi3, Tomofumi Miura4,5, Takuhiro Yamaguchi6, Yoshihisa Matsumoto4, Yuki Sumazaki Watanabe4, Yuko Uehara4, Ayumi Okizaki4, Akira Inoue7, Tatsuya Morita8, Hiroya Kinoshita4,9.   

Abstract

PURPOSE: The aim of study was to explore the potential association between patient's self-reported physical symptom management goals as personalized symptom goal (PSGs) and health-related quality of life (HRQOL) in cancer patients. The secondary outcome was to investigate the relationship between number of physical symptoms not achieving the PSGs and HRQOL in cancer patients.
METHODS: This single-center prospective observational study comprised 140 consecutive outpatients. We evaluated the PSGs and HRQOL using the Functional Assessment of Cancer Therapy-General (FACT-G). Patients were administered a self-report questionnaire, including reports on their physical symptom intensity and PSGs using Edmonton Symptom Assessment System-revised (ESAS-r) scores. We investigated the correlation between PSGs achievement (ESAS-r score ≤ PSG score) and FACT-G total scores, and relationship between and number of physical symptoms not achieving the PSGs (ESAS-r score > PSG score) and FACT-G total scores.
RESULTS: The patients who did not achieve PSGs of pain, tiredness, lack of appetite, and shortness of breath had a lower FACT-G total score (p < 0.05). Multivariate linear regression showed that higher number of physical symptoms not achieving the PSGs correlated with lower FACT-G scores (decreasing by 1.826 points for each such symptom, p < 0.01). Predictors of increased number of physical symptoms not achieving the PSGs were younger age and a higher symptom intensity of anxiety.
CONCLUSION: PSGs achievement was associated with HRQOL in cancer patients. Additionally, the number of unachieved PSGs were independent determinant of poor HRQOL, particularly in younger cancer patients and those with higher symptom intensity of anxiety.

Entities:  

Keywords:  Cancer patients; Personalized symptom goal; Physical symptom; Quality of life; Symptom management

Mesh:

Year:  2020        PMID: 31970517     DOI: 10.1007/s00520-020-05316-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  2 in total

1.  Symptom Clusters and Quality of Life in Hospice Patients with Cancer

Authors:  Suha Omran; Yousef Khader; Susan McMillan
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

2.  Symptom Severity, Anxiety, Depression, Self- Efficacy andzzm321990Quality of Life in Patients with Cancer

Authors:  Suha Omran; Susan Mcmillan
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  2 in total
  3 in total

1.  Dexamethasone 8 mg for Cancer-Related Fatigue in Inpatients with Advanced Cancer Undergoing Palliative Care: A Multicenter Phase II Trial.

Authors:  Tomofumi Miura; Ayumi Okizaki; Hideaki Hasuo; Eriko Satomi; Keita Tagami; Kengo Imai; Takashi Kojima; Hironaga Satake; Hiroto Ishiki; Akira Inoue; Takuhiro Yamaguchi
Journal:  Palliat Med Rep       Date:  2021-11-17

2.  Psychological barriers to the use of opioid analgesics for treating pain in patients with advanced recurrent cancer (BAROC): protocol for a multicentre cohort study.

Authors:  Takehiko Tsuno; Tatsuhiro Fujimiya; Takashi Kawaguchi; Ryota Yanaizumi; Keiko Kojima; Akime Miyasato; Kanako Azuma; Tomoya Saeki; Hironori Mawatari; Takashi Igarashi; Tomofumi Miura; Hiroyuki Ogura; Junichi Kondo; Tadashi Tanoue; Hiroshi Hamada; Yu Oyama; Akira Kotani; Takuhiro Yamaguchi; Hideki Hakamata
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

3.  Symptom Clusters and Quality of Life in Cervical Cancer Patients Receiving Concurrent Chemoradiotherapy: The Mediating Role of Illness Perceptions.

Authors:  Lan Zhang; Jia Wang; Tangzhen Chen; Min Tian; Qimin Zhou; Jianhua Ren
Journal:  Front Psychiatry       Date:  2022-01-31       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.